Skip to main content
Erschienen in: Clinical Research in Cardiology 6/2016

10.12.2015 | Original Paper

Impact of income status on prognosis of acute coronary syndrome patients during Greek financial crisis

verfasst von: George Andrikopoulos, Stylianos Tzeis, Dimitrios Terentes-Printzios, Christos Varounis, Charalampos Vlachopoulos, Ioannis Mantas, Sotirios Patsilinakos, Stylianos Lampropoulos, Christoforos Olympios, Athanasios Kartalis, Athanasios Manolis, Alexandros Gotsis, Filippos Triposkiadis, Themistoklis Tsaknakis, Ioannis Goudevenos, Ioannis Kaprinis, Athanasios Pras, Fotios Vasiliou, Emmanouil Skoumpourdis, Gerasimoula Sakka, Antonios Draganigos, Panos Vardas

Erschienen in: Clinical Research in Cardiology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The effect of income status on patient outcome merits investigation during periods of financial crisis. We evaluated the impact of income status on out-of-hospital prognosis in a cohort of acute coronary syndrome (ACS) patients, included in a countrywide study during a period of financial crisis.

Methods

The study is a secondary analysis of a prospective, multicenter, observational study–the PHAETHON study—enrolling consecutive ACS patients in 37 hospitals in Greece. Patients were classified as low or high income based on the reported net annual household income using as a cut-off point the relative poverty threshold for Greece of 12,000 Euros. The outcome measure was survival free of the primary composite endpoint (cardiovascular death, myocardial infarction, stroke/transient ischemic attack, urgent revascularization and urgent hospitalization due to cardiovascular causes).

Results

The study population included 794 patients. The administration rate of evidence-based medications was similar in the low- (n = 455) and high-income (n = 339) groups during hospitalization and upon discharge. In a median follow-up of 189 days (interquartile range: 180–212 days), low-income patients had 92 % higher risk of the combined endpoint as compared to high-income patients [Hazard ratio (HR):1.92, 95 % CI:1.25–2.94, p = 0.003]. The effect of low-income status on the combined outcome remained significant after adjustment for age, gender and depression (HR:1.59, 95 % CI:1.02–2.49; p = 0.043).

Conclusions

In a period of financial crisis, low income is a significant and independent predictor of poor out-of-hospital outcome in ACS patients. This association has profound implications and should be taken into consideration by public health policy makers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ndrepepa G, Tada T, Fusaro M et al (2012) Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 101(12):1003–1011CrossRefPubMed Ndrepepa G, Tada T, Fusaro M et al (2012) Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 101(12):1003–1011CrossRefPubMed
2.
Zurück zum Zitat Sinning C, Lillpopp L, Appelbaum S et al (2013) Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin Res Cardiol 102(7):495–503CrossRefPubMed Sinning C, Lillpopp L, Appelbaum S et al (2013) Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin Res Cardiol 102(7):495–503CrossRefPubMed
3.
Zurück zum Zitat Jakobsen L, Niemann T, Thorsgaard N et al (2012) Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention. Circ Cardiovasc Interv 5(5):641–648CrossRefPubMed Jakobsen L, Niemann T, Thorsgaard N et al (2012) Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention. Circ Cardiovasc Interv 5(5):641–648CrossRefPubMed
4.
Zurück zum Zitat Alter DA, Naylor CD, Austin P, Tu JV (1999) Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 341:1359–1367CrossRefPubMed Alter DA, Naylor CD, Austin P, Tu JV (1999) Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 341:1359–1367CrossRefPubMed
5.
Zurück zum Zitat Rao SV, Schulman KA, Curtis LH, Gersh BJ, Jollis JG (2004) Socioeconomic status and outcome following acute myocardial infarction in elderly patients. Arch Intern Med 164:1128–1133CrossRefPubMed Rao SV, Schulman KA, Curtis LH, Gersh BJ, Jollis JG (2004) Socioeconomic status and outcome following acute myocardial infarction in elderly patients. Arch Intern Med 164:1128–1133CrossRefPubMed
6.
Zurück zum Zitat Tonne C, Schwartz J, Mittleman M, Melly S, Suh H, Goldberg R (2005) Long-term survival after acute myocardial infarction is lower in more deprived neighborhoods. Circulation 111:3063–3070CrossRefPubMed Tonne C, Schwartz J, Mittleman M, Melly S, Suh H, Goldberg R (2005) Long-term survival after acute myocardial infarction is lower in more deprived neighborhoods. Circulation 111:3063–3070CrossRefPubMed
7.
Zurück zum Zitat Gemmill MC, Thomson S, Mossialos E (2008) What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int J Equity Health 7:12CrossRefPubMedPubMedCentral Gemmill MC, Thomson S, Mossialos E (2008) What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int J Equity Health 7:12CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Karanikolos M, Mladovsky P, Cylus J et al (2013) Financial crisis, austerity, and health in Europe. Lancet 381:1323–1331CrossRefPubMed Karanikolos M, Mladovsky P, Cylus J et al (2013) Financial crisis, austerity, and health in Europe. Lancet 381:1323–1331CrossRefPubMed
9.
Zurück zum Zitat Wagstaff A, van Doorslaer E, Calonge S et al (1992) Equity in the finance of health care: some international comparisons. J Health Econ 11:361–387CrossRefPubMed Wagstaff A, van Doorslaer E, Calonge S et al (1992) Equity in the finance of health care: some international comparisons. J Health Econ 11:361–387CrossRefPubMed
11.
Zurück zum Zitat Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial (2012) Third universal definition of MI. Eur Heart J 33:2551–2567CrossRefPubMed Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial (2012) Third universal definition of MI. Eur Heart J 33:2551–2567CrossRefPubMed
12.
Zurück zum Zitat Salomaa V, Niemelä M, Miettinen H et al (2000) Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation 101:1913–1918CrossRefPubMed Salomaa V, Niemelä M, Miettinen H et al (2000) Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation 101:1913–1918CrossRefPubMed
13.
Zurück zum Zitat Salomaa V, Miettinen H, Niemelä M et al (2001) Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health 55:475–482CrossRefPubMedPubMedCentral Salomaa V, Miettinen H, Niemelä M et al (2001) Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health 55:475–482CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Macintyre K, Stewart S, Chalmers J et al (2001) Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis. BMJ 322:1152–1153CrossRefPubMedPubMedCentral Macintyre K, Stewart S, Chalmers J et al (2001) Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis. BMJ 322:1152–1153CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Morrison C, Woodward M, Leslie W, Tunstall-Pedoe H (1997) Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register. BMJ 314:541–546CrossRefPubMedPubMedCentral Morrison C, Woodward M, Leslie W, Tunstall-Pedoe H (1997) Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register. BMJ 314:541–546CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Wang JY, Wang CY, Juang SY et al (2014) Low socioeconomic status increases short-term mortality of acute myocardial infarction despite universal health coverage. Int J Cardiol 172:82–87CrossRefPubMed Wang JY, Wang CY, Juang SY et al (2014) Low socioeconomic status increases short-term mortality of acute myocardial infarction despite universal health coverage. Int J Cardiol 172:82–87CrossRefPubMed
17.
Zurück zum Zitat van Lenthe FJ, Schrijvers CT, Droomers M, Joung IM, Louwman MJ, Mackenbach JP (2004) Investigating explanations of socio-economic inequalities in health: the Dutch GLOBE study. Eur J Public Health 14:63–70CrossRefPubMed van Lenthe FJ, Schrijvers CT, Droomers M, Joung IM, Louwman MJ, Mackenbach JP (2004) Investigating explanations of socio-economic inequalities in health: the Dutch GLOBE study. Eur J Public Health 14:63–70CrossRefPubMed
18.
Zurück zum Zitat Rathore SS, Berger AK, Weinfurt KP et al (2000) Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation 102:642–648CrossRefPubMed Rathore SS, Berger AK, Weinfurt KP et al (2000) Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation 102:642–648CrossRefPubMed
19.
Zurück zum Zitat Ferreira-González I, Marsal JR, Ribera A et al (2010) Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation. Circulation 122:1017–1025CrossRefPubMed Ferreira-González I, Marsal JR, Ribera A et al (2010) Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation. Circulation 122:1017–1025CrossRefPubMed
20.
Zurück zum Zitat Goldman DP, Joyce GF, Zheng Y (2007) Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 298:61–69CrossRefPubMed Goldman DP, Joyce GF, Zheng Y (2007) Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 298:61–69CrossRefPubMed
21.
Zurück zum Zitat Philipson TJ, Mozaffari E, Maclean JR (2010) Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome. Am J Manag Care 16:290–297PubMed Philipson TJ, Mozaffari E, Maclean JR (2010) Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome. Am J Manag Care 16:290–297PubMed
22.
Zurück zum Zitat Davlouros P, Gizas V, Stavrou K, Raptis G, Alexopoulos D (2013) DES thrombosis related to antiplatelet therapy noncompliance: a consequence of the Greek financial crisis. Int J Cardiol 168:4497–4499CrossRefPubMed Davlouros P, Gizas V, Stavrou K, Raptis G, Alexopoulos D (2013) DES thrombosis related to antiplatelet therapy noncompliance: a consequence of the Greek financial crisis. Int J Cardiol 168:4497–4499CrossRefPubMed
23.
Zurück zum Zitat Alan S, Crossley TF, Grootendorst P, Veall MR (2005) Distributional effects of “general population” prescription drug programs in Canada. Can J Econ 38:128–148CrossRef Alan S, Crossley TF, Grootendorst P, Veall MR (2005) Distributional effects of “general population” prescription drug programs in Canada. Can J Econ 38:128–148CrossRef
Metadaten
Titel
Impact of income status on prognosis of acute coronary syndrome patients during Greek financial crisis
verfasst von
George Andrikopoulos
Stylianos Tzeis
Dimitrios Terentes-Printzios
Christos Varounis
Charalampos Vlachopoulos
Ioannis Mantas
Sotirios Patsilinakos
Stylianos Lampropoulos
Christoforos Olympios
Athanasios Kartalis
Athanasios Manolis
Alexandros Gotsis
Filippos Triposkiadis
Themistoklis Tsaknakis
Ioannis Goudevenos
Ioannis Kaprinis
Athanasios Pras
Fotios Vasiliou
Emmanouil Skoumpourdis
Gerasimoula Sakka
Antonios Draganigos
Panos Vardas
Publikationsdatum
10.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 6/2016
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-015-0948-7

Weitere Artikel der Ausgabe 6/2016

Clinical Research in Cardiology 6/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.